Brand name for tirzepatide
Mounjaro
Mounjaro is Eli Lilly's brand of tirzepatide. Same ingredient, sold under this name for type 2 diabetes in adults.
See the full tirzepatide protocolQuick facts
| Active ingredient | Tirzepatide |
|---|---|
| Made by | Eli Lilly |
| Approved for | Type 2 diabetes in adults |
| First approved (US) | 2022 |
| How it comes | Single-dose pen, one shot a week under the skin |
How the label steps the dose up
| When | Dose |
|---|---|
| Weeks 1–4 | 2.5 mg once a week |
| Week 5 on | 5 mg once a week |
| If more is needed | Go up 2.5 mg at a time, at least 4 weeks apart |
| Top dose | 15 mg once a week |
The 2.5 mg start is there to let your stomach adjust. It isn't a treatment dose.
Pen or vial?
A Mounjaro pen is already measured, so there's nothing to mix and no units to work out. Syringe units only matter if you're drawing tirzepatide from a vial.
Mounjaro vs Zepbound
Zepbound is the same ingredient, approved for weight management.
Read about Zepbound →This page summarizes the public FDA label. It isn't from the guide and it isn't medical advice. Your prescriber's instructions come first. Official Mounjaro site. Mounjaro is a registered trademark of Eli Lilly. Amino Help isn't affiliated with them.